Herrscher et al reported in 2021 about a case developing abscopal response in metastatic BRAF V600E mutated malignant melanoma who had stopped targeted BRAF/MEK therapy 3 months prior when she received palliative RT of 20Gy/5# to bulky cervical adenopathy. The gene discussed is BRAF; the disease is melanoma.